BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3721137)

  • 21. The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome.
    Ehsanullah M; Lee DA; Williams T; Pollard P; Gazzard B
    Br J Clin Pharmacol; 1985 Mar; 19(3):301-5. PubMed ID: 3986085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.
    Harvey RF; Read AE
    Lancet; 1973 Jan; 1(7793):1-3. PubMed ID: 4118538
    [No Abstract]   [Full Text] [Related]  

  • 23. Physiological correlates of colonic motility in patients with irritable bowel syndrome.
    Bassotti G; Crowell MD; Cheskin LJ; Chami TN; Schuster MM; Whitehead WE
    Z Gastroenterol; 1998 Sep; 36(9):811-7. PubMed ID: 9795410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonic myoelectric activity in the irritable bowel syndrome.
    Snape WJ; Carlson GM; Cohen S
    Gastroenterology; 1976 Mar; 70(3):326-30. PubMed ID: 765183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human colonic motility.
    Misiewicz JJ
    Scand J Gastroenterol Suppl; 1984; 93():43-51. PubMed ID: 6374874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INTESTINAL MOTILITY IN MAN. 3. MECHANISMS OF CONSTIPATION AND DIARRHEA WITH PARTICULAR REFERENCE TO THE IRRITABLE COLON SYNDROME.
    WANGEL AG; DELLER DJ
    Gastroenterology; 1965 Jan; 48():69-84. PubMed ID: 14252755
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of colonic motility by cholecystokinin.
    Mangel AW; Brazer SR; Smith JW; Fitz JG; Taylor IL
    Ann Med; 1992 Oct; 24(5):341-2. PubMed ID: 1418916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a myoelectrical abnormality in the irritable colon syndrome?
    Taylor I; Darby C; Hammond P; Basu P
    Gut; 1978 May; 19(5):391-5. PubMed ID: 658769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome.
    Passaretti S; Sorghi M; Colombo E; Mazzotti G; Tittobello A; Guslandi M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):47-50. PubMed ID: 2744907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome.
    Taylor I; Basu P; Hammond P; Darby C; Flynn M
    Gut; 1980 Oct; 21(10):843-7. PubMed ID: 7439803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
    Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
    Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
    [No Abstract]   [Full Text] [Related]  

  • 33. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people.
    Camilleri M; Lee JS; Viramontes B; Bharucha AE; Tangalos EG
    J Am Geriatr Soc; 2000 Sep; 48(9):1142-50. PubMed ID: 10983917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis.
    Katschinski M; Lederer P; Ellermann A; Ganzleben R; Lux G; Arnold R
    Scand J Gastroenterol; 1990 Jul; 25(7):761-8. PubMed ID: 2204105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts in the management of the irritable bowel syndrome.
    Snape WJ
    Rev Gastroenterol Mex; 1994; 59(2):127-32. PubMed ID: 7991965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits.
    Miwa J; Echizen H; Matsueda K; Umeda N
    Digestion; 2001; 63(3):188-94. PubMed ID: 11351146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonic motility.
    Misiewicz JJ
    Gut; 1975 Apr; 16(4):311-4. PubMed ID: 1093950
    [No Abstract]   [Full Text] [Related]  

  • 39. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
    Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
    Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Colonic motility].
    Wianbeck M
    Z Gastroenterol; 1977 Mar; 15(3):209-14. PubMed ID: 871061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.